• Medientyp: E-Book
  • Titel: Decision-Making, Financial Risk Aversion and Behavioral Biases : The Role of Testosterone and Stress
  • Beteiligte: Nofsinger, John R. [VerfasserIn]; Patterson, Fernando [Sonstige Person, Familie und Körperschaft]; Shank, Corey A. [Sonstige Person, Familie und Körperschaft]
  • Erschienen: [S.l.]: SSRN, [2019]
  • Umfang: 1 Online-Ressource (57 p)
  • Sprache: Englisch
  • DOI: 10.2139/ssrn.3017977
  • Identifikator:
  • Schlagwörter: Testosterone ; Cortisol ; Physiology ; Stress ; Risk Aversion ; Disposition Effect
  • Entstehung:
  • Anmerkungen: Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments November 23, 2017 erstellt
  • Beschreibung: We examine the relation between testosterone, cortisol, and financial decisions in a sample of naïve investors. We find that testosterone level is positively related to excess risk-taking, whereas cortisol level is negatively related to excess risk-taking (correlation coefficient [r]: 0.75 and -0.21, respectively). Additionally, we find support for the dual-hormone hypothesis in a financial context. Specifically, the testosterone-to-cortisol ratio is significantly related to loss aversion. Individuals with a higher ratio are 3.4 times more likely to sell losing stocks (standard error [SE]: 1.63). Furthermore, we find a positive feedback loop between financial success, testosterone, and cortisol. Specifically, financial success is significantly related to higher post-trial testosterone and cortisol by a factor of 0.53 (SE: 0.14). Finally, we find that in a competitive environment, testosterone level increases significantly, leading to greater risk-taking than in noncompetitive environment. Overall, this study underscores the importance of the endocrine system on financial decision-making. Broader implications of this study include, but are not limited to, investors looking to optimize financial performance, industry human resources, market regulators, and academia
  • Zugangsstatus: Freier Zugang